Amalgamated Bank’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8K Hold
4,047
﹤0.01% 2526
2025
Q1
$9K Buy
4,047
+443
+12% +$985 ﹤0.01% 2426
2024
Q4
$6K Hold
3,604
﹤0.01% 2661
2024
Q3
$7K Hold
3,604
﹤0.01% 2619
2024
Q2
$13K Hold
3,604
﹤0.01% 2305
2024
Q1
$10K Sell
3,604
-10,841
-75% -$30.1K ﹤0.01% 2443
2023
Q4
$25K Sell
14,445
-1,073
-7% -$1.86K ﹤0.01% 2554
2023
Q3
$16K Hold
15,518
﹤0.01% 2750
2023
Q2
$18K Buy
15,518
+1,117
+8% +$1.3K ﹤0.01% 2788
2023
Q1
$22K Sell
14,401
-2,160
-13% -$3.3K ﹤0.01% 2605
2022
Q4
$41K Hold
16,561
﹤0.01% 2506
2022
Q3
$70K Buy
16,561
+266
+2% +$1.12K ﹤0.01% 2317
2022
Q2
$45K Buy
16,295
+1,252
+8% +$3.46K ﹤0.01% 2541
2022
Q1
$86K Sell
15,043
-1,268
-8% -$7.25K ﹤0.01% 2250
2021
Q4
$149K Sell
16,311
-177
-1% -$1.62K ﹤0.01% 2014
2021
Q3
$176K Sell
16,488
-959
-5% -$10.2K ﹤0.01% 2015
2021
Q2
$271K Buy
17,447
+4,984
+40% +$77.4K ﹤0.01% 1929
2021
Q1
$202K Sell
12,463
-1,240
-9% -$20.1K 0.01% 1484
2020
Q4
$290K Buy
13,703
+77
+0.6% +$1.63K 0.01% 1245
2020
Q3
$202K Sell
13,626
-403
-3% -$5.97K 0.01% 1318
2020
Q2
$206K Sell
14,029
-1,084
-7% -$15.9K 0.01% 1289
2020
Q1
$177K Sell
15,113
-535
-3% -$6.27K ﹤0.01% 1400
2019
Q4
$368K Buy
15,648
+2,631
+20% +$61.9K 0.01% 1292
2019
Q3
$241K Sell
13,017
-197
-1% -$3.65K 0.01% 1449
2019
Q2
$246K Buy
13,214
+2,667
+25% +$49.7K 0.01% 1474
2019
Q1
$258K Buy
10,547
+419
+4% +$10.3K 0.01% 1352
2018
Q4
$263K Buy
+10,128
New +$263K 0.01% 1251
2018
Q3
Sell
-9,745
Closed -$379K 1525
2018
Q2
$379K Buy
+9,745
New +$379K 0.01% 1179